Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines Phase 1/2 studies evaluating the pharmacokinetics and safety of Epidiferphane in combination with taxanes in breast cancer p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epidiferphane
  • Taxanes (Taxane class)

Snippet

Sponsor: University of Florida | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING